Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Centenarian SIRT6 variants elevate SIRT6 protein and enhance cellular senescence resistance.

Research square·2026
Same author

Efficacy of traditional Chinese exercises on cognitive function in older adults: a systematic review and meta-analysis of randomised controlled trials.

Age and ageing·2026
Same author

Questions of the future in aging and longevity research at the GIMM Festival.

Nature aging·2026
Same author

Supplements and Drugs Are Associated With Biological Age in a Cohort of Exceptionally Healthy Individuals.

Aging cell·2026
Same author

Obesity and biological aging across the life course: A geroscience framework for metabolic health.

Metabolism: clinical and experimental·2026
Same author

Foundations of Gerophysics.

Aging·2026

関連する実験動画

Updated: Jun 30, 2026

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
14:22

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

12.7K

ラミノパシーについては,SUN1をダイヤルする.

Yousin Suh1, Brian K Kennedy

  • 1Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Cell
|May 1, 2012
PubMed
まとめ
この要約は機械生成です。

A型核ラミンの変異は,プロゲリアと筋縮を含む疾患のグループであるラミノパシーを引き起こす. 核内膜タンパク質であるSUN1の発現が増加すると,これらの状態で病理が引き起こされます.

科学分野:

  • 細胞生物学 細胞生物学
  • 遺伝学 遺伝学とは
  • 分子生物学は分子生物学である.

背景:

  • ラミノパシーとは,A型核ラミンの変異によって生じる遺伝疾患の一種である.
  • これらの疾患は,プロゲリアや筋力衰弱を含む様々な形で表れ,細胞の完全性と機能における核層の重要な役割を強調しています.

さらに関連する動画

The Lambda Select cII Mutation Detection System
07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

7.5K
Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
06:23

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

1.2K

関連する実験動画

Last Updated: Jun 30, 2026

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
14:22

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

12.7K
The Lambda Select cII Mutation Detection System
07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

7.5K
Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
06:23

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

1.2K